Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians’ experiences

Marck, Claudia H; Hunter, Assunta; Butler, Ernest; Allan, Michelle; Edward, Karen‐Leigh; Giles, Andrew; Kulkarni, Jayashri; Rajendran, Deepa; Shaw, Sally F.; Grech, Lisa

doi:10.1016/j.msard.2021.103362

Multiple Sclerosis and Related Disorders

2022

DOI: 10.1016/j.msard.2021.103362

|View full text |Cite

Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians’ experiences

Claudia H Marck

Assunta Hunter

Ernest Butler

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

2024

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 6 publications

(3 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 5 – 11 In addition, their close and frequent interaction with patients gives them the opportunity to detect more subtle symptoms that are often overlooked in follow-up office visits by neurologists. 12 , 13 …”

mentioning

confidence: 99%

“…[5][6][7][8][9][10][11] In addition, their close and frequent interaction with patients gives them the opportunity to detect more subtle symptoms that are often overlooked in follow-up office visits by neurologists. 12,13 Although nurses cannot prescribe DMTs, understanding their treatment preferences and priorities may help to improve their role in a complicated treatment landscape with different side effect profiles and safety monitoring needs. 3,14 The aim of this study was to assess nurses' preferences toward relapsing-remitting MS treatments according to different attributes of efficacy, safety, and mode of administration.…”

mentioning

confidence: 99%

“…They usually participate in patient education and aspects related to disease care as well as on how treatments are administered, the importance of adherence, and potential side effects 5–11. In addition, their close and frequent interaction with patients gives them the opportunity to detect more subtle symptoms that are often overlooked in follow-up office visits by neurologists 12,13…”

mentioning

confidence: 99%

See 2 more Smart Citations

Preferences Toward Attributes of Disease-Modifying Therapies: The Role of Nurses in Multiple Sclerosis Care

Río-Muñoz

Azanza-Munarriz

Becerril-Ríos

et al. 2022

Journal of Neuroscience Nursing

View full text Add to dashboard Cite

BACKGROUND: Nurses play an essential role in coordinating the care of patients with multiple sclerosis (MS) throughout their disease trajectory in a complex treatment landscape. The aim of this study was to assess nurses' preferences toward different disease-modifying therapy attributes. METHODS: We conducted a multicenter, noninterventional, cross-sectional study in collaboration with the Sociedad Española de Enfermería Neurológica. Nurses actively involved in MS care were invited to participate in the study. Prevention of disability progression, preservation of cognitive function, side effect profile and safety monitoring, and method of administration were the treatment attributes tested. Conjoint analysis was used to assess preferences in 8 simulated treatment options and rank them from most to least preferred. RESULTS: A total of 98 nurses were included in the study. The mean (SD) age was 44.7 (9.8) years, and 91.8% were female with a mean (SD) time of experience in MS care of 7.5 (5.4) years. Participants prioritized preservation of cognition (38.6%), followed by preventing disability progression (35.2%) and side effect risk and safety monitoring (13.5%). Route and frequency of administration were the least preferred attributes (7.4% and 5.3%, respectively). Estimated utilities were consistent across the sample according to sociodemographic and professional practice characteristics. CONCLUSIONS: Nurses' preferences toward treatments were mainly driven by efficacy attributes. This information may support the role of nurses in the multidisciplinary management of MS facilitating shared decision making.

show abstract

mentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Preferences Toward Attributes of Disease-Modifying Therapies: The Role of Nurses in Multiple Sclerosis Care

Río-Muñoz

Azanza-Munarriz

Becerril-Ríos

et al. 2022

Journal of Neuroscience Nursing

View full text Add to dashboard Cite

show abstract

Improving Parkinson's Disease Care through Systematic Screening for Depression

Marras,

Meyer,

Liu

et al. 2024

Movement Disord Clin Pract

View full text Add to dashboard Cite

BackgroundDepression is common in Parkinson's disease (PD) but is underrecognized clinically. Although systematic screening is a recommended strategy to improve depression recognition in primary care practice, it has not been widely used in PD care.MethodsThe 15‐item Geriatric Depression Scale (GDS‐15) was implemented at 5 movement disorders clinics to screen PD patients. Sites developed processes suited to their clinical workflow. Qualitative interviews with clinicians and patients provided information on feasibility, acceptability, and perceived utility.ResultsPrior to implementation, depression screening was recorded in 12% using a formal instrument; 64% were screened informally by clinical interview, and no screening was recorded in 24%. Of 1406 patients seen for follow‐up care during the implementation period, 88% were screened, 59% using the GDS‐15 (self‐administered in 51% and interviewer administered in 8%), a nearly 5‐fold increase in formal screening. Lack of clinician or staff time and inability to provide the GDS‐15 to the patient ahead of the visit were the most commonly cited reasons for lack of screening using the GDS‐15; 378 (45%) patients completing the GDS‐15 screened positive for depression, and 137 were enrolled for a 12‐month prospective follow‐up. Mean GDS‐15 scores improved from 8.8 to 7.0 (P < 0.0001) and the 39‐item Parkinson's Disease Questionnaire emotional subscore from 42.2 to 36.7 (P = 0.0007).ConclusionsDepression screening in PD using a formal instrument can be achieved at much higher levels than is currently practiced, but there are barriers to implementing this in clinical practice. An individual site‐specific process is necessary to optimize screening rates.

show abstract

Depression and anxiety in multiple sclerosis. Review of a fatal combination

Jellinger

2024

J Neural Transm

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Assessment and treatment of depression in people with multiple sclerosis: A qualitative analysis of specialist clinicians’ experiences

Cited by 6 publications

References 23 publications

Preferences Toward Attributes of Disease-Modifying Therapies: The Role of Nurses in Multiple Sclerosis Care

Preferences Toward Attributes of Disease-Modifying Therapies: The Role of Nurses in Multiple Sclerosis Care

Improving Parkinson's Disease Care through Systematic Screening for Depression

Depression and anxiety in multiple sclerosis. Review of a fatal combination

Contact Info

Product

Resources

About